Characterization of mammalian N-degrons and development of heterovalent inhibitors of the N-end rule pathway†

The N-end rule pathway relates the in vivo half-life of a protein with its N-terminal residue. Recent understanding of the molecular mechanism underlying N-degron recognition implies that the yeast N-degrons may not be identical to those of mammals. Here we re-evaluate the role of N-terminal amino acids as degradation determinants through an in vitro degradation assay and computational docking analysis. To take advantage of the distinct binding modes of type 1 and type 2 destabilizing residues, we developed and optimized heterovalent inhibitors of the N-end rule pathway. These small-molecules effectively delayed the degradation of the physiological N-end rule substrates in vitro and in living cells, including cardiomyocytes, suggesting that the heterovalent inhibitors could be applied to various cardiac diseases that originate from abnormal N-end rule regulation.

[1]  Binh Khanh Mai,et al.  Development and characterization of monomeric N-end rule inhibitors through in vitro model substrates. , 2013, Journal of medicinal chemistry.

[2]  Yong Tae Kwon,et al.  The N-end rule pathway. , 2012, Annual review of biochemistry.

[3]  Min Jae Lee,et al.  Characterization of Arginylation Branch of N-end Rule Pathway in G-protein-mediated Proliferation and Signaling of Cardiomyocytes* , 2012, The Journal of Biological Chemistry.

[4]  Min Jae Lee,et al.  Emerging roles of the ubiquitin-proteasome system in the steroid receptor signaling , 2012, Archives of pharmacal research.

[5]  Min Jae Lee,et al.  Liposome-Mediated Cancer Gene Therapy: Clinical Trials and their Lessons to Stem Cell Therapy , 2012 .

[6]  Yong Tae Kwon,et al.  The N-end rule pathway: emerging functions and molecular principles of substrate recognition , 2011, Nature Reviews Molecular Cell Biology.

[7]  G. Bassel,et al.  Homeostatic response to hypoxia is regulated by the N-end rule pathway in plants , 2011, Nature.

[8]  Y. Kwon,et al.  The molecular principles of N-end rule recognition , 2010, Nature Structural &Molecular Biology.

[9]  G. Kozlov,et al.  Structural basis of substrate recognition and specificity in the N-end rule pathway , 2010, Nature Structural &Molecular Biology.

[10]  Joonhee Kim,et al.  Structural basis for the recognition of N-end rule substrates by the UBR box of ubiquitin ligases , 2010, Nature Structural &Molecular Biology.

[11]  Alexander Varshavsky,et al.  N-Terminal Acetylation of Cellular Proteins Creates Specific Degradation Signals , 2010, Science.

[12]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[13]  T. Baker,et al.  Molecular basis of substrate selection by the N-end rule adaptor protein ClpS , 2009, Proceedings of the National Academy of Sciences.

[14]  R. Kane,et al.  Multivalency-assisted control of intracellular signaling pathways: application for ubiquitin- dependent N-end rule pathway. , 2009, Chemistry & biology.

[15]  T. Baker,et al.  The molecular basis of N-end rule recognition. , 2008, Molecular cell.

[16]  Min Jae Lee,et al.  Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway , 2008, Proceedings of the National Academy of Sciences.

[17]  Y. Kwon,et al.  The mammalian N-end rule pathway: new insights into its components and physiological roles. , 2007, Trends in biochemical sciences.

[18]  J. Stewart.  Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements , 2007, Journal of molecular modeling.

[19]  Gerhard Klebe,et al.  PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations , 2007, Nucleic Acids Res..

[20]  Andrey Tovchigrechko,et al.  GRAMM-X public web server for protein–protein docking , 2006, Nucleic Acids Res..

[21]  René Bernards,et al.  A Genomic and Functional Inventory of Deubiquitinating Enzymes , 2005, Cell.

[22]  Min Jae Lee,et al.  RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Min Jae Lee,et al.  A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons , 2005, Molecular and Cellular Biology.

[24]  Michel F Sanner,et al.  A component-based software environment for visualizing large macromolecular assemblies. , 2005, Structure.

[25]  J. Harper,et al.  Interwoven Ubiquitination Oscillators and Control of Cell Cycle Transitions , 2004, Science's STKE.

[26]  A. Ciechanover,et al.  Ubiquitin as a central cellular regulator , 2004, Cell.

[27]  A. Varshavsky,et al.  Female Lethality and Apoptosis of Spermatocytes in Mice Lacking the UBR2 Ubiquitin Ligase of the N-End Rule Pathway , 2003, Molecular and Cellular Biology.

[28]  A. Varshavsky,et al.  An Essential Role of N-Terminal Arginylation in Cardiovascular Development , 2002, Science.

[29]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[30]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Alexander Varshavsky,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[32]  Junmei Wang,et al.  How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000, J. Comput. Chem..

[33]  V. Denenberg,et al.  Altered Activity, Social Behavior, and Spatial Memory in Mice Lacking the NTAN1p Amidase and the Asparagine Branch of the N-End Rule Pathway , 2000, Molecular and Cellular Biology.

[34]  M. Tyers,et al.  Proteolysis and the cell cycle: with this RING I do thee destroy. , 2000, Current opinion in genetics & development.

[35]  A. Varshavsky,et al.  Bivalent Inhibitor of the N-end Rule Pathway* , 1999, The Journal of Biological Chemistry.

[36]  S. Elledge,et al.  Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. , 1999, Science.

[37]  N. Copeland,et al.  The mouse and human genes encoding the recognition component of the N-end rule pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. H. Strauss,et al.  Requirement for an Aromatic Amino Acid or Histidine at the N Terminus of Sindbis Virus RNA Polymerase , 1998, Journal of Virology.

[39]  A. Varshavsky.  The N‐end rule pathway of protein degradation , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[40]  A. Varshavsky,et al.  The N-end rule: functions, mysteries, uses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Varshavsky,et al.  Yeast N-terminal Amidase , 1995, The Journal of Biological Chemistry.

[42]  J. H. Strauss,et al.  Sindbis virus RNA polymerase is degraded by the N-end rule pathway. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Tobias,et al.  Universality and structure of the N-end rule. , 1989, The Journal of biological chemistry.

[44]  A. Ciechanover,et al.  Degradation of proteins with acetylated amino termini by the ubiquitin system , 1989, Science.

[45]  A. Varshavsky,et al.  In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.

[46]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[47]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .